- About Us
Specialties for All Ages
- Autism Spectrum Disorders
- Brain Injury / Sports Concussions
- ADHD / Learning Differences
- Epilepsy / Seizure Disorders
- Developmental & Intellectual Disabilities
- Behavioral Difficulties / Disorders
- Neuropsychiatric / Mood & Anxiety Disorders
- Tourette Syndrome / Tic Disorders
- Headaches / Migraines
- Cerebral Palsy
- Sleep Disorders
- Other Neurological Disorders
CRCNJ is enrolling children Ages 13-17 diagnosed with ADHD in a research study of an investigational medication. Join a Clinical Trial Symptoms of ADHD include difficulty remembering information, difficulty concentrating, trouble organizing or completing tasks, and procrastination. Qualified participants receive study-related psychological evaluation(s), compensation for time and travel and a 3 month supply of an FDA-approved medication to treat ADHD at no cost on completion of study.
CRCNJ is enrolling teens Ages 12-18 in a Perampanel study for partial onset seizures. Join a Clinical Trial This study is for teens that are already on a stable dose of one to three antiepileptic drugs and are continuing to experience breakthrough seizures. The goal of the study is to evaluate the effects of perampanel on cognition and growth. This study lasts about 20 weeks with an extension phase of about 33 weeks.
CRCNJ is enrolling children Ages 4-16 in a Pregabalin study for partial onset seizures. Join a Clinical Trial This study is for children who are already on a stable dose of one to three antiepileptic drugs and are continuing to experience breakthrough seizures. The goal of this study is to evaluate if it is effective and well tolerated. The study lasts for about 21 weeks. Children may be eligible to participate in a 1 year extension study at the end of this study.
CRCNJ is enrolling children Ages 2-12 in a Perampanel study for all seizure types. Join a Clinical Trial This is an open-label study to evaluate the pharmacokinetics, and to generate preliminary safety, tolerability, and efficacy of perampanel oral suspension when given as an adjunctive therapy in pediatric subjects with epilepsy. This study lasts 1 year with the possibility of further extension.
CNNH BLOG: Effects of Motivation and Medication on Electrophysiological Markers of Response Inhibition in Children with ADHD
An interesting study from Biological Psychiatry on the importance of behavioral approaches to ADHD.
From the Desk of Laura Henderson, MA BCBA and Nicole Pelliciari, MS BCBA… Hearing that your child has an Autism Spectrum Disorder (ASD) diagnosis can cause feelings of sadness, disbelief and …
A majority of patients hospitalized for traumatic brain injury demonstrated major depressive disorder (MDD) one year after the injury, according to this study. High rates of depression were associated with …
From the Desk of Mark Mintz, MD… One of the burdens of having Epilepsy is the unpredictability of a sudden convulsive seizure (i.e. an event that involves loss and/or impairment …
FROM CNNH PRESS WATCH… As part of May being Tourette Syndrome Awareness Month, check out this interesting article about Tourette Syndrome and U.S. Goalkeeper Tim Howard’s public and private …